Also in this playlist...
This transcript is automatically generated
Fifteen minutes -- -- at the floor of the New York Stock Exchange.
The cold enough to the -- for a change that's right denizens narrow we are seeing the data -- to be at the be all without barrows and the NASDAQ Composite.
Is the one that we've been watching here to see whether or not it would be down for a seventh straight day in which case.
We haven't seen that since basically last November almost eleven months and -- that was during the eurozone the crisis that we saw.
Over in the eurozone and prior to that the last time we saw that.
Was back in 2008 during our financial crisis out.
We'll see whether or not the NASDAQ manages to hold on to some gains here today.
The Dow Jones industrials up about a half a percent in the SP 500 also.
But not -- we're keeping a keen eye on drug stocks and particularly Eli Lilly and this is as they came out.
With some findings on the on the trial judge that they've been working on meeting in the late stage goals that they had four it's basically for gastric cancer.
And it's coming out really nicely into showing survival rates improving and and now they may tested for other cancers as -- it's up four and a quarter percent -- now.
Back -- article thank you very much you'll see fourteen minutes from now of course -- the next.
Filter by section